'%2F%3E%3Cpath%20d%3D'M6.5%2025%2016%207%2025.5%2025'%20fill%3D'none'%20stroke%3D'%23fff'%20stroke-width%3D'3.8'%20stroke-linecap%3D'round'%20stroke-linejoin%3D'round'%2F%3E%3Ccircle%20cx%3D'16'%20cy%3D'19'%20r%3D'3.2'%20fill%3D'%23fff'%2F%3E%3C%2Fsvg%3E){kind=small}
Nephrocare Health Services Limited
NEPHROPLUS (NSE) · NEPHROPLUS (BSE 544647) · ISIN INE428V01029 · Healthcare Service Provider · Est. 2009 · listed 2025 · website
Not on any surveillance list
In Q1 FY27 (quarter to 30 June 2026, standalone), revenue was ₹170.38 cr and profit after tax ₹12.56 cr.
Next: Board meeting: financial results on 3 November 2026.
Quarterly results
| Quarter | Revenue | Profit after tax | EPS (₹) | Filed |
|---|---|---|---|---|
| Q1 FY27 standalone | ₹170.38 cr | ₹12.56 cr | 1.22 | 11 Aug 2026 |
| Q4 FY26 standalone | ₹164.33 cr | ₹10.89 cr | 1.06 | 19 May 2026 |
| Q3 FY26 standalone | ₹160.66 cr | ₹8.45 cr | 0.88 | 10 Feb 2026 |
Balance sheet
| As of | Total equity | Borrowings | Total assets |
|---|---|---|---|
| 31 Mar 2026 standalone | ₹970.91 cr | ₹11.72 cr | ₹1,135.05 cr |
Shareholding
| Promoter | FII | DII | Public |
|---|---|---|---|
| 58.31% | 11.73% | 8.11% | 41.69% |
Latest filings
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Polar Capital Funds PLC 28 September 2026 · BSE
- Please find enclosed herewith Transcripts for the investors Earning call held on August 12, 2026. 19 August 2026 · BSE
- Nephrocare Health Services Limited has informed the Exchange about Transcript 19 August 2026 · NSE
- Declartion of voting results along with scrutinizers report of the 17th AGM of the Company. 13 August 2026 · BSE
- Summary of proceedings of the 17th AGM of the Company. 12 August 2026 · BSE
Other companies in Healthcare Service Provider
- Dr. Lal Path Labs Ltd.
- Metropolis Healthcare Limited
- Thyrocare Technologies Limited
- Vijaya Diagnostic Centre Limited
- Krsnaa Diagnostics Limited
- One Global Service Provider Limited
- Suraksha Diagnostic Limited
- Chandan Healthcare Limited
Figures as filed by the company with NSE and BSE; surveillance status from the exchanges' lists. Updated 30 October 2026.
Information and calculation tools by Rachid Asen. Not investment advice or research. Facts from company filings and the exchanges' lists, for information only; not a recommendation to buy, sell or hold. Verify with the exchange.